Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UCB Director's Dealing 2018

Jul 6, 2018

4017_mrq_2018-07-06_bd217c12-a583-4cd4-96a5-e6e23d31c0fd.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Transparency notifications BlackRock, Inc.

  • 2 notifications referring to situation on 29 June and 2 July 2018
  • Threshold crossed: 5%
  • Latest shareholding: 4,91%

Brussels (Belgium), 6 July 2018 – 20:00 (CEST) – regulated information

1. Summary of the notifications

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency notifications both dated 3 July 2018 from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.).

In the first notification BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights and equivalent financial instruments by its affiliates, its shareholding in UCB SA has increased and has crossed the 5% threshold on 29 June 2018.

In the second notification, BlackRock, Inc. has informed that, following a disposal of UCB shares with voting rights and equivalent financial instruments by its affiliates, its shareholding in UCB SA/NV has decreased and has crossed downward the 5% threshold on 2 July 2018.

On 29 June 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 9 000 969 UCB shares with voting rights (versus 5 836 096 shares in its previous notification dated 2 June 2017), representing 4.63% of the total number of shares issued by the company (194 505 658) (versus 3.00% in the notification dated 2 June 2017), as well as 790 335 equivalent financial instruments (versus 379 722 in its previous notification dated 2 June 2017) representing 0.41% of the total number of shares issued by the company (versus 0.20% in the notification dated 2 June 2017).

On 2 July 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 8 780 237 UCB shares with voting rights, representing 4.51% of the total number of shares issued by the company, as well as 779 207 equivalent financial instruments, representing 0.40% of the total number of shares issued by the company.

2. Content of the notifications

2.1 The information mentioned hereafter was identical in both notifications:

  • Reason for the notification: Acquisition or disposal of voting securities or voting rights
  • Notification by: A parent undertaking or a controlling person.

Persons subject to the notification requirement:

Name Address (for legal entities)
BlackRock, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited 20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG Max-Joseph-Straße 6, Munich, 80333, Germany
BlackRock Asset Management North Asia Limited 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central,
Hong Kong
BlackRock Financial Management, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National
Association
400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia)
Limited
Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC 1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd. 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan
  • Threshold crossed (in %): 5%
  • Denominator: 194 505 658
  • Chain of controlled undertakings through which the holding is effectively held: Please see the full chain of control in the PDF which is attached to the notifications.

  • 2.2. The first transparency notification dated 3 July 2018 included the following specific information:

  • Date on which the threshold is crossed: 29 June 2018
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc. 0 0 0.00%
BlackRock (Netherlands) B.V. 18,125 20,988 0.01%
BlackRock (Singapore) Limited 6,980 7,282 0.00%
BlackRock Advisors (UK) Limited 683,470 1,398,006 0.72%
BlackRock Advisors, LLC 76,325 226,091 0.12%
BlackRock Asset Management
Canada Limited
59,233 149,100 0.08%
BlackRock Asset Management
Deutschland AG
230,489 250,965 0.13%
BlackRock Asset Management North
Asia Limited
760 1,340 0.00%
BlackRock Financial Management,
Inc.
60,509 165,960 0.09%
BlackRock Fund Advisors 2,075,606 2,404,596 1.24%
BlackRock Institutional Trust
Company, National Association
1,906,593 3,196,340 1.64%
BlackRock International Limited 6,461 25,297 0.01%
BlackRock Investment Management
(Australia) Limited
43,395 70,951 0.04%
BlackRock Investment Management
(UK) Limited
231,376 390,245 0.20%
BlackRock Investment Management,
LLC
264,477 335,992 0.17%
BlackRock Japan Co., Ltd. 172,297 357,816 0.18%
Subtotal 5,836,096 9,000,969 4.63%
Subtotal
TOTAL 9,000,969 0 4.63% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Expiration date Exercise period or
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Advisors (UK) Limited Contract for Difference 4,807 0.00% cash
BlackRock Advisors, LLC Contract for Difference 15,350 0.01% cash
BlackRock Institutional Trust
Company, National Association
Contract for Difference 374,995 0.19% cash
BlackRock International Limited Contract for Difference 10,692 0.01% cash
BlackRock Investment Management
(UK) Limited
Contract for Difference 242,390 0.12% cash
BlackRock Investment Management,
LLC
Contract for Difference 134,263 0.07% cash
BlackRock Investment Management
(UK) Limited
Securities Lent 7,838 0.00% physical
TOTAL 790,335 0.41%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 9,791,304 5.03%

Additional information:

The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 5%.

  • 2.3. The second transparency notification dated 3 July 2018 includes the following specific information:
  • Date on which the threshold is crossed: 2 July 2018
  • Notified details:

UCB
News

A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the
securities
Linked to
securities
Not linked to the
securities
BlackRock, Inc. $\bf 0$ $\mathbf 0$ 0.00%
BlackRock (Netherlands) B.V. 20.988 20.988 0.01%
BlackRock (Singapore) Limited 7,282 7,282 0.00%
BlackRock Advisors (UK) Limited 1,398,006 1,281,041 0.66%
BlackRock Advisors, LLC 226,091 226,091 0.12%
BlackRock Asset Management
Canada Limited
149,100 149,100 0.08%
BlackRock Asset Management
Deutschland AG
250,965 252,088 0.13%
BlackRock Asset Management North
Asia Limited
1,340 8,693 0.00%
BlackRock Financial Management,
Inc.
165,960 166,219 0.09%
BlackRock Fund Advisors 2,404,596 2,399,275 1.23%
BlackRock Institutional Trust
Company, National Association
3,196,340 3,210,225 1.65%
BlackRock International Limited 25,297 25,297 0.01%
BlackRock Investment Management
(Australia) Limited
70,951 70,951 0.04%
BlackRock Investment Management
(UK) Limited
390,245 400,217 0.21%
BlackRock Investment Management,
LLC
335,992 340,477 0.18%
BlackRock Japan Co., Ltd. 357,816 222,293 0.11%
Subtotal 9,000,969 8,780,237 4.51%
TOTAL 8,780,237 $\mathbf 0$ 4.51% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent
financial instruments
Type of financial instrument Expiration date Exercise period or
date
# of voting rights
that may be
acquired if the
instrument is
exercised
% of voting rights Settlement
BlackRock Investment Management
(UK) Limited
Securities Lent 17,914 0.01% physical
BlackRock Advisors (UK) Limited Contract for Difference 4,807 0.00% cash
BlackRock Advisors, LLC Contract for Difference 15,350 0.01% cash
BlackRock Institutional Trust
Company, National Association
Contract for Difference 366,382 0.19% cash
BlackRock International Limited Contract for Difference 10,196 0.01% cash
BlackRock Investment Management
(UK) Limited
Contract for Difference 230,295 0.12% cash
BlackRock Investment Management,
LLC
Contract for Difference 134,263 0.07% cash
TOTAL 779,207 0.40%

Additional information: The disclosure obligation arose due to total holding in voting rights for BlackRock, Inc. going below 5%.

3. Further information

This press release and the detailed transparency notification are available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news